Literature DB >> 9821970

Autocatalytic activation of human legumain at aspartic acid residues.

S Halfon1, S Patel, F Vega, S Zurawski, G Zurawski.   

Abstract

Human legumain was characterized following overexpression in a murine cell line as the C-terminal Ig-fusion protein. Upon acid treatment, the prolegumain autoproteolyzed distal to two aspartic acid residues to yield a highly active form. The ability of mature legumain to cleave after aspartic acid residues was confirmed with a small peptide substrate. Substitution of alanine for the putative catalytic cysteine, or for either of two strictly conserved histidine residues, partly or wholly eliminated autoactivation but not the ability of wild-type legumain to correctly process the variants to the properly sized proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821970     DOI: 10.1016/s0014-5793(98)01281-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  An intracellular protease of the crenarchaeon Sulfolobus solfataricus, which has sequence similarity to eukaryotic peptidases of the CD clan.

Authors:  Annamaria Guagliardi; Laura Cerchia; Mosè Rossi
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  Structural determinants for peptide-bond formation by asparaginyl ligases.

Authors:  Xinya Hemu; Abbas El Sahili; Side Hu; Kaho Wong; Yu Chen; Yee Hwa Wong; Xiaohong Zhang; Aida Serra; Boon Chong Goh; Dina A Darwis; Ming Wei Chen; Siu Kwan Sze; Chuan-Fa Liu; Julien Lescar; James P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-23       Impact factor: 11.205

3.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

4.  Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile.

Authors:  Elfriede Dall; Hans Brandstetter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

5.  The families of papain- and legumain-like cysteine proteinases from embryonic axes and cotyledons of Vicia seeds: developmental patterns, intracellular localization and functions in globulin proteolysis.

Authors:  J Fischer; C Becker; S Hillmer; C Horstmann; B Neubohn; A Schlereth; V Senyuk; A Shutov; K Müntz
Journal:  Plant Mol Biol       Date:  2000-05       Impact factor: 4.076

6.  Activation of human prolegumain by cleavage at a C-terminal asparagine residue.

Authors:  J M Chen; M Fortunato; A J Barrett
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

Review 7.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

8.  Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase.

Authors:  Zhixue Liu; Sung-Wuk Jang; Xia Liu; Dongmei Cheng; Junmin Peng; Manuel Yepes; Xiao-jiang Li; Steve Matthews; Colin Watts; Masahide Asano; Ikuko Hara-Nishimura; Hongbo R Luo; Keqiang Ye
Journal:  Mol Cell       Date:  2008-03-28       Impact factor: 17.970

9.  Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.

Authors:  Zhentao Zhang; Seong Su Kang; Xia Liu; Eun Hee Ahn; Zhaohui Zhang; Li He; P Michael Iuvone; Duc M Duong; Nicholas T Seyfried; Matthew J Benskey; Fredric P Manfredsson; Lingjing Jin; Yi E Sun; Jian-Zhi Wang; Keqiang Ye
Journal:  Nat Struct Mol Biol       Date:  2017-07-03       Impact factor: 15.369

10.  Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.

Authors:  Gustavo Basurto-Islas; Inge Grundke-Iqbal; Yunn Chyn Tung; Fei Liu; Khalid Iqbal
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.